Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Operating Expenses (2018 - 2025)

Viemed Healthcare's Operating Expenses history spans 8 years, with the latest figure at $32.8 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 13.11% year-over-year to $32.8 million; the TTM value through Dec 2025 reached $124.4 million, up 13.83%, while the annual FY2025 figure was $124.4 million, 13.83% up from the prior year.
  • Operating Expenses reached $32.8 million in Q4 2025 per VMD's latest filing, roughly flat from $32.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $32.8 million in Q4 2025 to a low of $7.5 million in Q4 2021.
  • Average Operating Expenses over 5 years is $22.7 million, with a median of $23.4 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: fell 19.11% in 2021, then surged 196.46% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $7.5 million in 2021, then surged by 196.46% to $22.3 million in 2022, then rose by 10.28% to $24.6 million in 2023, then grew by 18.15% to $29.0 million in 2024, then increased by 13.11% to $32.8 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Operating Expenses are $32.8 million (Q4 2025), $32.7 million (Q3 2025), and $29.6 million (Q2 2025).